Pharma lobby sues Trump administration over Medicare drug pricing rule
The pharmaceutical industry’s top lobby group filed suit to invalidate part of the Trump administration’s benchmarking efforts for Medicare drug prices tied to lower overseas costs, calling it illegal overreach.